Stock Comparison
DXCM vs SYK
DexCom Inc and Stryker Corporation side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$33.38B
$128.32B
P/E (TTM)
35.0
34.6
Forward P/E
34.9
22.3
Price/Sales
6.7
5.0
Price/Book
12.7
5.4
EV/EBITDA
21.2
20.1
Dividend Yield
—
0.76%
Profitability
Net Margin
19.31%
13.21%
Operating Margin
21.45%
21.34%
Return on Equity
38.50%
16.50%
Return on Assets
10.30%
8.16%
Growth (YoY)
Revenue Growth
13.10%
9.40%
Earnings Growth
43.60%
44.10%
Price & Risk
Beta
1.4
0.8
52-Week High
$91.48
$391.42
52-Week Low
$54.84
$282.58
Analyst Target
$93.44
$382.04
Compare DXCM and SYK your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.